A novel method for purifying bluetongue virus with high purity by co-immunoprecipitation with agarose protein A

Virology Journal

Volumn 7, Issue , 2010, Pages

  Zhen, Song ^a   Changyuan, Dong ^a   Lulu, Wang ^a   Dong E, Chen ^a   Guoming, Bi ^a   Ming, Dai ^a   Jun, Liu ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE PROTEIN A; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BLUETONGUE ORBIVIRUS; IMMUNOPRECIPITATION; NONHUMAN; SEROTYPE; TISSUE CULTURE; TRANSMISSION ELECTRON MICROSCOPY; VIRION;

BLUETONGUE VIRUS; ORBIVIRUS; OVIS ARIES; REOVIRIDAE;

EID: 77953311120     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-126     Document Type: Article

References (18)

1. Phylogenetic comparison of the serotype-specific VP2 protein of bluetongue and related orbiviruses. LI Pritchard AR Gould, Virus Res 1995 39 2 3 10.1016/0168-1702(95)00094-1 (Pubitemid 26054786)
2. Sequence conservation of the outer capsid protein, VP5, of bluetongue virus, a contrasting feature to the outer capsid protein VP2. S Oldfield T Hirasawa P Roy, J Gen Virol 1991 72 449 51 10.1099/0022-1317-72-2-449 1847179
3. Phylogenetic relationships of bluetongue viruses based on gene S7. WC Wilson HC Ma EH Venter AA van Djik BS Seal JO Mecham, Virus Res 2000 67 2 141 51 Erratum in: Virus Res. 73 201-2 10.1016/S0168-1702(00)00138-6 10867193
4. Selective in vitro cytotoxic effect of human cancer cells by Bluetongue virus-10. H Jun CY Dong KK Li DE Chen K Liang J Liu, Acta Oncol 2008 47 124 134
5. Interactions between the inner and outer capsids of bluetongue virus. EL Nason R Rothagel SK Mukherjee AK Kar M Forzan BV Prasad P Roy, J Virol 2004 78 8059 8067 10.1128/JVI.78.15.8059-8067.2004 15254177
6. Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep. H Huismans NT Van Der Walt M Cloete BJ Erasmus, Virology 1987 61 3589 3595
7. Purification and properties of virus particles, infectious subviral particles, and cores of bluetongue virus serotype 1 and 4. PPC Mertens JN Burroughs J Anderson, Virology 1987 157 375 386 10.1016/0042-6822(87)90280-7 3029978
8. Enhanced infectivities of modified bluetongue virus for two insect cell lines for two Culicoides vector species. PPC Mertens JN Burroughs A Walton MP Welby H Fu RS O'Hara SM Brookes PS Mellor, Virology 1995 217 582 593 10.1006/viro.1996.0153
9. Bluetongue virus proteins. P Roy, J Gen Virol 1989 73 3051 3064 10.1099/0022-1317-73-12-3051
10. Cross-neutralisation of genetic reassortants of bluetongue virus serotypes 20 and 21. JA Cowley BM Gorman, Vet Microbiol 1989 19 37 51 10.1016/0378-1135(89)90089-8 2466366
11. Analysis of the roles of bluetongue virus outer capsid proteins VP2 and VP5 in determination of virus serotype. PPC Mertens S Pedley J Cowley JN Burroughs AH Corteyn MH Jeggo AM Jennings BM Gorman, Virology 1989 170 561 565 10.1016/0042-6822(89)90447-9 2543130
12. Death mode of Hep-3B and A549 tumor cells induced by bluetongue virus strain HbC3. J Chen J Hu CY Dong K Liang Y Dai J Gao, Zhonghua Zhong Liu Za Zhi 2007 29 505 9 18069629
13. Bluetongue Virus Therapy of MA782 Breast Adenocarcinom a Grown Subcutaneously in Mice. Luo Xiang Dong Changyuan Guo Shufang, Medical Journal of Wuhan University 2004 25 372 379
14. Isolation and characterization of two types of bluetongue virus particles. SA Martin HJ Zweerink, Virology 1972 50 495 506 10.1016/0042-6822(72) 90400-X 4344192
15. Structure of the bluetongue virus capsid. DW Verwoerd HJ Els EM De Villiers H Huismans, J Virol 1972 10 783 794 4117349
16. Characterization of the tubules associated with the replication of three different orbiviruses. H Huismans HJ Els, Virology 1979 92 397 406 10.1016/0042-6822(79)90144-2 218352
17. Reovirus Therapy of Tumors with Activated Ras Pathway. MC Coffey LE Strong PA Forsyth, Science 1998 282 1332 1334 10.1126/science.282.5392.1332 9812900
18. Isolation of a human melanoma adapted Newcastle disease virus mutant with highly selective replication patterns. T Ahlert V Schirrmacher, Cancer Res 1990 50 5962 5968 2203523